Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proton and Heavy Ion Beam Radiation Versus Photon Beam Radiation for Newly Diagnosed Glioblastoma: A Multi-center Prospective Phase 3 Randomized Control Clinical Trial.

NCT04536649 is registered in ClinicalTrials.gov with Shanghai Proton and Heavy Ion Center as lead sponsor.

NCT NCT04536649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04536649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proton and Heavy Ion Beam Radiation Versus Photon Beam Radiation for Newly Diagnosed Glioblastoma: A Multi-center Prospective Phase 3 Randomized Control Clinical Trial.
Lead sponsor
Shanghai Proton and Heavy Ion Center
Phase
Phase 3
Overall status
Unknown status
Start date
October 1, 2020
Completion date
September 30, 2025
Enrollment
369 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma